No abstract available
MeSH terms
-
Adult
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Boronic Acids / administration & dosage
-
Bortezomib
-
Cesarean Section
-
Chemoradiotherapy
-
Cisplatin / administration & dosage
-
Combined Modality Therapy
-
Contraindications
-
Cyclophosphamide / administration & dosage
-
Cytarabine / administration & dosage
-
Dexamethasone / administration & dosage
-
Dexamethasone / therapeutic use
-
Doxorubicin / administration & dosage
-
Etoposide / administration & dosage
-
Fatal Outcome
-
Female
-
Hematopoietic Stem Cell Transplantation
-
Humans
-
Hypercalcemia / etiology
-
Idarubicin / administration & dosage
-
Infant, Newborn
-
Lenalidomide
-
Male
-
Melphalan / administration & dosage
-
Methylprednisolone / administration & dosage
-
Multiple Myeloma / diagnosis
-
Multiple Myeloma / drug therapy*
-
Myeloma Proteins / analysis
-
Osteolysis / diagnosis
-
Osteolysis / etiology
-
Plasmacytoma / diagnosis
-
Plasmacytoma / genetics
-
Plasmacytoma / therapy*
-
Postpartum Period
-
Pregnancy
-
Pregnancy Complications, Neoplastic / diagnosis
-
Pregnancy Complications, Neoplastic / drug therapy
-
Pregnancy Complications, Neoplastic / therapy*
-
Pregnancy Complications, Neoplastic / urine
-
Pregnancy Outcome
-
Pyrazines / administration & dosage
-
Remission Induction
-
Spinal Cord Compression / etiology
-
Thalidomide / administration & dosage
-
Thalidomide / analogs & derivatives
-
Thoracic Vertebrae / pathology
-
Transplantation, Autologous
Substances
-
Boronic Acids
-
Myeloma Proteins
-
Pyrazines
-
Cytarabine
-
Thalidomide
-
Bortezomib
-
Etoposide
-
Dexamethasone
-
Doxorubicin
-
Cyclophosphamide
-
Lenalidomide
-
Cisplatin
-
Melphalan
-
Methylprednisolone
-
Idarubicin